Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

EMG appoints two new senior members

April 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB

A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).   EMG is the voice of …
Appointment

Glyn Edwards appointed as chief executive of Summit

April 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit

Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive. Edwards will take up the …
Appointment

New Europe-wide approach for the classification of commercially confidential information and personal data in MAAs

April 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Heads of Medicines Agencies(HMA) and the European Medicines Agency (EMA) have adopted a joint guidance document, providing a consistent …
News
Press release

Catalent Extends Development and Analytical Solutions Capabilities in Swindon, UK

April 3, 2012 Research and Development

Somerset, NJ – March 22, 2012 — Catalent Pharma Solutions today announces the completion of new Development and Analytical Solutions’ …
News
Press release
Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012 Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …
News

Standardised equipment and centralised spirometry for optimal data quality

April 3, 2012 Research and Development

IntroductionWhen developing the treatments for asthma and COPD, pharmaceutical companies utilise pulmonary function testing (PFT) to determine each compound’s efficacy. …
Feature
Thought Leadership

Considerations with dual site production

April 3, 2012 Research and Development

There are generally two options available when looking to expand storage capacity – build to develop existing facilities or select …
Feature
Thought Leadership

Michael Cola resigns from Shire

April 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire

Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm.  “On behalf of …
Appointment

Moving Towards a Risk-Based approach to Clinical Trial Management

April 3, 2012 Research and Development

Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …
Feature
Thought Leadership
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012 Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …
News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
Appointment
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …
Appointment

Prostate cancer drug extends life after chemotherapy

March 29, 2012 Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …
News
GSK image

GSK settles cancer patent dispute

March 28, 2012 Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …
News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012 Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026